Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027" report to their offering.

Irritable Bowel Syndrome (IBS) is a functional bowel disorder which incorporates a group of symptoms but includes abdominal pain and disturbed defecation. IBS is divided into several subtypes including:

- Diarrhoea predominant (IBS-D)

- Constipation predominant (IBS-C)

- Alternating (IBS-A)

- Pain predominant.

These subtypes are identified by the dominant symptoms that the patient experiences.

This report provides the current prevalent population for Irritable Bowel Syndrome across 12 Major Markets (USA, Canada, France, Germany, Russia, Italy, Spain, UK, Brazil, Japan, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Irritable Bowel Syndrome have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Irritable Bowel Syndrome include:

  • Abdominal pain
  • Abdominal cramping
  • Bloated/Gassy feeling
  • Gas (Flatulence)
  • Diarrhoea
  • Constipation
  • Mucus in stools

Key Topics Covered:

  1. Introduction
  2. Cause of the Disease
  3. Risk Factors & Prevention
  4. Diagnosis of the Disease
  5. Variation by Geography/Ethnicity
  6. Disease Prognosis & Clinical Course
  7. Key comorbid conditions/Features associated with the disease
  8. Methodology for quantification of patient numbers
  9. Top-line prevalence for Irritable Bowel Syndrome
  10. Features of Irritable Bowel Syndrome patients
  11. Abbreviations used in the report
  12. Patient-Based Offering
  13. Online Pricing Data and Platforms
  14. References
  15. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/4jfpj4/irritable_bowel

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Gastroenterology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Gastroenterology